Tumor mutational burden (TMB) and microsatellite instability (MSI) are established critical biomarkers for ICI response [31,32]; thus, we further explored the correlation between PSMB9 expression and these genomic features across multiple cancer types. This evidence concerns the gene PSMB9 and neoplasm.